To assess whether VEGFR-1 plays a role in the aggressive behavior of this GBM cell subset, 18 patient-derived GSC lines (Table 2) were analyzed for VEGFR-1 and VEGFR-2 expression by qRT-PCR. The gene discussed is KDR; the disease is glioblastoma.